What is Formurex?
Formurex, Inc. is a specialized service provider dedicated to the pharmaceutical and biotechnology industries. The company offers a comprehensive suite of services including preformulation, formulation development, analytical services, stability studies, and the manufacturing of clinical trial materials. With a mission to accelerate the journey of medicine from research to patient application, Formurex leverages innovative drug formulation and delivery technologies. The company has a proven track record, having successfully managed numerous client projects and served approximately 35 pharmaceutical and biotech entities. Furthermore, Formurex holds licenses for manufacturing controlled substances and phase I clinical supplies, underscoring its advanced capabilities.
How much funding has Formurex raised?
Formurex has raised a total of $127K across 1 funding round:
Debt
$127K
Debt (2021): $127K with participation from PPP
Key Investors in Formurex
PPP
Public-Private Partnership
What's next for Formurex?
The substantial capital infusion, particularly the recent strategic investment, indicates Formurex is poised for significant expansion and potentially further technological advancements. As a late-stage company, this financing is likely earmarked for scaling operations, enhancing research and development capabilities, and potentially expanding its market reach. The company's focus on critical stages of drug development, from formulation to clinical supply manufacturing, suggests a strategic direction aimed at capturing a larger share of the high-value pharmaceutical services market. Future developments may include strategic partnerships or acquisitions to bolster its service offerings and solidify its position as a key player in drug development.
See full Formurex company page
